FDA Approves New Diabetes Drug. By Cole Petrochko, Staff Writer, MedPage Today Original article posted on MedPage Today. WASHINGTON – The FDA has. A new diabetes treatment was approved by the U. S. Food and Drug Administration on Friday. The FDA said in its news release Friday that Tresiba’s overall efficacy and safety were evaluated in numerous trials involving more than 3, 700 patients with type 1 and type diabetes. Get the news. Eli Lilly and Co. won final approval to put its Lantus-lookalike insulin on the market. FDA approves Lilly, Boehringer diabetes drug.

New drug approvals news from Drugs. com. Comprehensive and up-to-date drug news for both consumers and healthcare professionals. FDA Approves Basaglar (insulin glargine) for Type 1 and Type 2 Diabetes – December 17, 2015. A diabetic applies an Insulin pen injection in Vienna November 13, 2012. The U. S. Food and Drug Administration (FDA) approved Basaglar, an insulin glargine injection for the treatment of patients with type 2 diabetes.

Fda Approves New Diabetes Drug

New drug approvals news from Drugs. com. Comprehensive and up-to-date drug news for both consumers and healthcare professionals. FDA Approves Basaglar (insulin glargine) for Type 1 and Type 2 Diabetes – December 17, 2015. A diabetic applies an Insulin pen injection in Vienna November 13, 2012. The U. S. Food and Drug Administration (FDA) approved Basaglar, an insulin glargine injection for the treatment of patients with type 2 diabetes. GSK Australia opens new facility to reduce global vaccination costs. News and analysis related to the Food and Drug Administration. UPDATE 1-U. S. FDA approves Eli Lilly’s Basaglar diabetes drug Wednesday, 16 Dec 2015 | 5: 44 PM ET. The Food and Drug Administration approved a new form of Sanofi’s pen-like injector, Lantus, from drugmakers Eli Lilly and Co.

FDA approves cheaper version of top-selling diabetes drug. The Food and Drug Administration approved a new form of Sanofi’s pen-like injector, Lantus, from drugmakers Eli Lilly and Co. and Boehringer Ingelheim. 2015 The Associated Press. FDA approves cheaper version of top-selling diabetes drug. By The Associated Press Posted Dec 16th, 2015 3: 01pm. The Food and Drug Administration approved a new form of Sanofi’s pen-like injector, called Lantus, from drugmakers. The three drugmakers reached an agreement in September allowing the launch of the new drug. The FDA approved a new inhaled insulin product. Huge news, D-Friends: the new rapid-acting inhalable insulin known as Afrezza has just obtained FDA approval! MannKind has spent years trying to gain approval for this treatment, first submitting a new drug application in May 2009. FDA approves cheaper version of top-selling diabetes drug.


Share.

Comments are closed.